CIK 0001835597
- Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- 4 Planned sale Chief Medical Officer sold 1,586 shares at an average $18.06 ($28,637)
- 4 Planned sale SVP, Clinical Development sold 8,656 shares at an average $18.08 ($156,460)
- 4 Open-market sale SVP, Chem. Mfg & Controls sold 10,000 shares at $13.41 ($134,100)
- 4/A Open-market buy 10% owner bought 879,970 shares at $12.00 ($10,559,640)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,557,593 shares at $10.64 ($27,212,790)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 1,694 shares at $4.17 ($7,056)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President and CEO sold 2,381 shares at $16.04 ($38,188)
Page 4 of 7 · 122 filings